Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Language | 5 | 2024 | 328 | 0.820 |
Why?
|
| Brain Mapping | 7 | 2024 | 638 | 0.800 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2021 | 224 | 0.790 |
Why?
|
| Pancreatic Neoplasms | 4 | 2021 | 5235 | 0.680 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2024 | 7922 | 0.660 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 1408 | 0.580 |
Why?
|
| Oncogenes | 1 | 2020 | 700 | 0.560 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 443 | 0.550 |
Why?
|
| Brain Neoplasms | 10 | 2024 | 4980 | 0.470 |
Why?
|
| Cordotomy | 3 | 2020 | 47 | 0.440 |
Why?
|
| Glioma | 6 | 2022 | 1969 | 0.430 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2021 | 1819 | 0.420 |
Why?
|
| Pain, Intractable | 3 | 2020 | 179 | 0.410 |
Why?
|
| Connectome | 2 | 2021 | 114 | 0.320 |
Why?
|
| Cancer Pain | 3 | 2020 | 344 | 0.320 |
Why?
|
| Image Enhancement | 4 | 2018 | 555 | 0.310 |
Why?
|
| Contrast Media | 4 | 2021 | 1510 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 9083 | 0.220 |
Why?
|
| Prolyl Hydroxylases | 1 | 2021 | 8 | 0.200 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2021 | 35 | 0.200 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2021 | 31 | 0.190 |
Why?
|
| Optic Nerve Neoplasms | 2 | 2018 | 37 | 0.180 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2019 | 9 | 0.170 |
Why?
|
| Pinocytosis | 1 | 2019 | 28 | 0.170 |
Why?
|
| Syndecan-1 | 1 | 2019 | 54 | 0.160 |
Why?
|
| Wernicke Area | 1 | 2017 | 11 | 0.150 |
Why?
|
| Visual Pathways | 1 | 2018 | 91 | 0.150 |
Why?
|
| Telomere | 1 | 2020 | 533 | 0.140 |
Why?
|
| Orbit | 1 | 2018 | 209 | 0.140 |
Why?
|
| Ubiquitination | 1 | 2019 | 577 | 0.140 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2016 | 83 | 0.140 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 14875 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 1467 | 0.130 |
Why?
|
| Chemokine CXCL5 | 1 | 2015 | 14 | 0.130 |
Why?
|
| Speech | 1 | 2017 | 138 | 0.130 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2017 | 295 | 0.130 |
Why?
|
| Cognition | 1 | 2021 | 981 | 0.120 |
Why?
|
| Mice | 6 | 2021 | 36026 | 0.120 |
Why?
|
| Smad4 Protein | 1 | 2015 | 200 | 0.120 |
Why?
|
| Pain Management | 1 | 2020 | 716 | 0.120 |
Why?
|
| Middle Cerebellar Peduncle | 1 | 2014 | 5 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2015 | 277 | 0.120 |
Why?
|
| Eye Neoplasms | 1 | 2016 | 259 | 0.120 |
Why?
|
| Humans | 31 | 2024 | 270825 | 0.110 |
Why?
|
| Carotid Arteries | 2 | 1992 | 248 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 1708 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2017 | 726 | 0.110 |
Why?
|
| Brain Stem Neoplasms | 1 | 2014 | 102 | 0.110 |
Why?
|
| Brain Diseases | 2 | 2018 | 414 | 0.110 |
Why?
|
| Male | 23 | 2024 | 128398 | 0.100 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2011 | 13 | 0.100 |
Why?
|
| Brain | 5 | 2024 | 4245 | 0.100 |
Why?
|
| Prostatic Neoplasms | 2 | 2021 | 5992 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 2125 | 0.100 |
Why?
|
| Adult | 18 | 2024 | 81540 | 0.100 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2010 | 5 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 1469 | 0.100 |
Why?
|
| Erdheim-Chester Disease | 1 | 2011 | 55 | 0.090 |
Why?
|
| Sweat | 1 | 2010 | 11 | 0.090 |
Why?
|
| Hand | 1 | 2012 | 175 | 0.090 |
Why?
|
| Animals | 6 | 2021 | 62801 | 0.090 |
Why?
|
| Motor Cortex | 1 | 2012 | 126 | 0.090 |
Why?
|
| Spinal Diseases | 1 | 2011 | 131 | 0.090 |
Why?
|
| Inflammation | 1 | 2020 | 2526 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 1014 | 0.090 |
Why?
|
| Female | 21 | 2024 | 148456 | 0.090 |
Why?
|
| Smell | 1 | 2010 | 133 | 0.090 |
Why?
|
| Cues | 1 | 2010 | 200 | 0.080 |
Why?
|
| Blood Flow Velocity | 1 | 1991 | 543 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 634 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2010 | 215 | 0.080 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2008 | 12 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 2989 | 0.080 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2008 | 40 | 0.080 |
Why?
|
| Neuroimaging | 1 | 2012 | 402 | 0.080 |
Why?
|
| Middle Aged | 14 | 2024 | 90030 | 0.080 |
Why?
|
| Preoperative Period | 2 | 2020 | 349 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2017 | 1367 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 121 | 0.070 |
Why?
|
| Genomics | 1 | 2017 | 2818 | 0.070 |
Why?
|
| Young Adult | 6 | 2024 | 22035 | 0.060 |
Why?
|
| Anxiety Disorders | 1 | 2010 | 719 | 0.060 |
Why?
|
| Atlases as Topic | 1 | 2024 | 46 | 0.060 |
Why?
|
| Aged | 10 | 2024 | 73188 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2007 | 373 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 1178 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 593 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2006 | 341 | 0.060 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2014 | 2168 | 0.050 |
Why?
|
| Cerebral Blood Volume | 1 | 2021 | 7 | 0.050 |
Why?
|
| Disease Progression | 3 | 2019 | 6892 | 0.050 |
Why?
|
| Adolescent | 5 | 2020 | 32508 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2020 | 63 | 0.050 |
Why?
|
| Gray Matter | 1 | 2021 | 60 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2020 | 91 | 0.040 |
Why?
|
| Anisotropy | 2 | 2014 | 186 | 0.040 |
Why?
|
| Seizures | 1 | 2006 | 1030 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2024 | 39679 | 0.040 |
Why?
|
| Executive Function | 1 | 2021 | 149 | 0.040 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2019 | 32 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2021 | 13361 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 664 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2020 | 250 | 0.040 |
Why?
|
| Craniotomy | 1 | 2021 | 306 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 513 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2024 | 1547 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 435 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2020 | 261 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 163 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 4881 | 0.040 |
Why?
|
| Nerve Net | 1 | 2021 | 271 | 0.040 |
Why?
|
| Pia Mater | 1 | 2017 | 17 | 0.040 |
Why?
|
| Memory | 1 | 2021 | 442 | 0.040 |
Why?
|
| Telomerase | 1 | 2020 | 533 | 0.040 |
Why?
|
| Orbital Diseases | 1 | 2018 | 121 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2017 | 2847 | 0.030 |
Why?
|
| Optic Nerve Diseases | 1 | 2018 | 111 | 0.030 |
Why?
|
| Colon | 1 | 2020 | 689 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 284 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2020 | 12206 | 0.030 |
Why?
|
| Algorithms | 1 | 2007 | 3905 | 0.030 |
Why?
|
| Child | 4 | 2020 | 30343 | 0.030 |
Why?
|
| Orbital Neoplasms | 1 | 2018 | 238 | 0.030 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2015 | 58 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2018 | 16919 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 618 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 671 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 2616 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 1124 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 5184 | 0.030 |
Why?
|
| Software | 1 | 2021 | 1360 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 2502 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 4067 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2017 | 1018 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 7782 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 4990 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 2669 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 965 | 0.020 |
Why?
|
| Shyness | 1 | 2010 | 2 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 1991 | 92 | 0.020 |
Why?
|
| Galvanic Skin Response | 1 | 2010 | 18 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2010 | 112 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 5325 | 0.020 |
Why?
|
| Facial Expression | 1 | 2010 | 41 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 169 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2015 | 1229 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 180 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 360 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 1992 | 734 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 6185 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 3169 | 0.020 |
Why?
|
| Heart Rate | 1 | 2010 | 762 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 1173 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 7302 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2017 | 33821 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 916 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2015 | 5493 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2017 | 5679 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 22452 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 30940 | 0.010 |
Why?
|
| Electricity | 1 | 1992 | 18 | 0.010 |
Why?
|
| Muscles | 1 | 1992 | 462 | 0.010 |
Why?
|